Insiders · CNTA

Thomas Templeman

Officer at Centessa Pharmaceuticals plc (CNTA)

Thomas Templeman has filed 10 insider reports with the SEC since February 2021, as officer at Centessa Pharmaceuticals plc (CNTA) and officer at Nuvation Bio Inc. (NUVB). Thomas Templeman made no open-market purchases or sales in the last 12 months. The latest filing, on April 4, 2023, reports shares withheld for taxes or exercise price at Centessa Pharmaceuticals plc (CNTA).

Filings
10
Companies
2
Bought on market
None
Sold on market
$17.8K

Companies where Thomas Templeman is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Centessa Pharmaceuticals plc logo
CNTA
Centessa Pharmaceuticals plc
Officer188,244$17.8KApr 4, 2023
Nuvation Bio Inc. logo
NUVB
Nuvation Bio Inc.
Officersince February 2021$3.80Feb 12, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Thomas Templeman with

Other insiders at the same companies

Questions about Thomas Templeman

What is Thomas Templeman's role at Centessa Pharmaceuticals plc?
Thomas Templeman reports to the SEC as officer at Centessa Pharmaceuticals plc (CNTA), according to the latest filing on April 4, 2023. Thomas Templeman has also filed as officer at Nuvation Bio Inc. (NUVB).
How many shares does Thomas Templeman own?
After the latest filing that states it, Thomas Templeman directly owned 188,244 shares of Centessa Pharmaceuticals plc (CNTA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Thomas Templeman bought or sold stock recently?
The most recent open-market sale was on October 3, 2022: sold 4,458 shares of Centessa Pharmaceuticals plc (CNTA) for $17.8K at an average of $4.00.
How do I get alerts when Thomas Templeman files?
Follow Thomas Templeman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Thomas Templeman (SEC CIK 0001654274). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR · Get this as JSON